Prevalence and Intensity of Musculoskeletal (Joint) Pain in Patients with Hyperuricemia Among Population of Lahore

Authors

  • Muhammad Ashir Rehman Malik Gulab Devi Hospital, Lahore, Pakistan
  • Subayyal Iftikhar Gulab Devi Hospital, Lahore, Pakistan
  • Zohaib Zafar Gulab Devi Hospital, Lahore, Pakistan
  • Suleman Ashiq Riphah International University, Lahore, Pakistan

DOI:

https://doi.org/10.61919/jhrr.v6i2.1933

Keywords:

Hyperuricemia; Serum uric acid; Musculoskeletal pain; Joint involvement; Visual analogue scale.

Abstract

Background: Hyperuricemia is increasingly prevalent and may contribute to musculoskeletal pain even in the absence of overt gout. Early identification of joint involvement patterns remains limited in South Asian populations. Objective: To determine the prevalence, anatomical distribution, and intensity of musculoskeletal joint pain among hyperuricemic adults in Lahore and evaluate the association between serum uric acid (SUA) levels and pain severity. Methods: A cross-sectional observational study was conducted in 102 adults aged 20–60 years with laboratory-confirmed hyperuricemia recruited from two tertiary hospitals in Lahore. Pain intensity was measured using a 10-cm Visual Analogue Scale. Joint involvement was recorded by anatomical site. Pearson correlation assessed associations between SUA and pain intensity and between SUA and joint-specific involvement. Results: Males constituted 55.9% of participants. The knee was the most prevalent symptomatic joint (27.5%), followed by ankle (24.5%) and shoulder (17.6%). The MTP joint showed the strongest association with SUA (r = 0.302, p = 0.002). SUA demonstrated a moderate positive correlation with pain intensity (r = 0.564, 95% CI 0.415–0.684, p < 0.001). Conclusion: Elevated serum uric acid levels are significantly associated with increased musculoskeletal pain intensity. While knee pain is most prevalent, the MTP joint shows the strongest metabolic association. Early metabolic assessment and lifestyle modification may reduce musculoskeletal morbidity.

Downloads

Download data is not yet available.

References

Tang SCW. Gout: A Disease of Kings. Contrib Nephrol. 2017;192:77–81.

Paul BJ, Anoopkumar K, Krishnan V. Asymptomatic hyperuricemia: is it time to intervene? Clin Rheumatol. 2017;36(12):2637–44.

Hong F, Zheng A, Xu P, Wang J, Xue T, Dai S, et al. High-Protein Diet Induces Hyperuricemia in a New Animal Model for Studying Human Gout. Int J Mol Sci. 2020;21(6).

Janssen CA, Oude Voshaar MAH, Vonkeman HE, Krol M, van de Laar MAFJ. Compliance and persistence to urate-lowering therapy. Clin Rheumatol. 2018;37(8):2291–6.

Chalès G. How should we manage asymptomatic hyperuricemia? Joint Bone Spine. 2019;86(4):437–43.

Qidwai W, Jawaid MJ. Frequency of Uric Acid Levels in Pakistani Population. 2017.

Wang H, Zhang H, Sun L, Guo W. Roles of hyperuricemia in metabolic syndrome. Am J Transl Res. 2018;10(9):2749.

George C, Minter DA. Hyperuricemia. StatPearls. 2020.

Perez-Ruiz F, Dalbeth N, Bardin T. Uric acid and gout. Adv Ther. 2015;32(1):31–41.

Pascual E, Martínez A, Ordóñez S. Mechanism of urate crystal nucleation. 2013.

Park DY, Kim YS, Ryu SH, Jin YS. Sedentary behavior and hyperuricemia. Vasc Health Risk Manag. 2019;15:291–9.

Shaikhomar O, Header E. Dietary Etiological Factors in Hyperuricemia. 2020.

Zeng J, Zhang J, Li Z, et al. Prediction model for hyperuricemia. 2020.

Comberg H-U, Schach S. Hyperuricemia and musculoskeletal pain. Open Pain J. 2016;9(1).

Kakutani-Hatayama M, et al. Nonpharmacological management of gout. 2017.

Wang S, Pillinger M, Krasnokutsky S, Barbour K. Hyperuricemia and knee osteoarthritis. Osteoarthritis Cartilage. 2019;27.

Wu J, Qiu L, Cheng X, et al. Hyperuricemia and cardiovascular risk. Sci Rep. 2017;7:5456.

Kusumayanti GAD, Dewantari NM. Low purine diet and physical activity. 2017.

Jonsson H, Aspelund T, Eiriksdottir G, et al. Hyperuricemia and hand joint pain. PLoS One. 2019;14:e0221474.

Raja S, Kumar A, Aahooja RD, et al. Prevalence of hyperuricemia in Karachi. 2019.

Martinon F, Pétrilli V, Mayor A, et al. Gout-associated uric acid crystals activate inflammasome. Nature. 2006;440:237–41.

Richette P, Doherty M, Pascual E, et al. 2018 updated EULAR gout recommendations. Ann Rheum Dis. 2018;77:31–8.

Krasnokutsky S, Oshinsky C, Attur M, et al. Uric acid and osteoarthritis progression. Arthritis Rheum. 2017;69:123–31.

Krishnan E, Kwoh CK, Schumacher HR, et al. Socioeconomic correlates of hyperuricemia. Arthritis Rheum. 2012;64:398–405.

Downloads

Published

2026-02-28

How to Cite

Muhammad Ashir Rehman Malik, Subayyal Iftikhar, Zohaib Zafar, & Suleman Ashiq. (2026). Prevalence and Intensity of Musculoskeletal (Joint) Pain in Patients with Hyperuricemia Among Population of Lahore. Journal of Health and Rehabilitation Research, 6(2), 1–7. https://doi.org/10.61919/jhrr.v6i2.1933

Issue

Volume 6, Issue 2 (February 2026)

Section

Articles

License

Copyright (c) 2026 Muhammad Ashir Rehman Malik, Subayyal Iftikhar, Zohaib Zafar, Suleman Ashiq

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Public Licensing Terms

This work is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). Under this license:

  • You are free to share (copy and redistribute the material in any medium or format) and adapt (remix, transform, and build upon the material) for any purpose, including commercial use.
  • Attribution must be given to the original author(s) and source in a manner that is reasonable and does not imply endorsement. If changes were made to the material, this must be indicated.
  • No additional restrictions may be applied that conflict with the terms of this license.

For more details, visit: https://creativecommons.org/licenses/by/4.0/